Effects of L-thyroxine treatment on heart functions in infants with congenital hypothyroidism

Alev Arslan1, Veysel Nijat Baş2, Salih Uytun3

  • 1Division of Pediatric Cardiology Başkent University Faculty of Medicine, Adana Dr. Turgut Noyan Medical and Research Center, Adana.

Insights

Congenital hypothyroidism (CH) in newborns can impair heart function. Early levothyroxine (L-T4) treatment can reverse this diastolic dysfunction, as shown by echocardiography.

Area of Science:

  • Neonatal cardiology
  • Pediatric endocrinology

Background:

  • Congenital hypothyroidism (CH) can impair cardiac function in newborns.
  • Levothyroxine (L-T4) substitution therapy is crucial for reversing these effects.

Purpose of the Study:

  • To investigate cardiac function in neonates with CH using echocardiography.
  • To assess changes in heart function after initiating L-T4 therapy.

Main Methods:

  • Included 30 neonates with CH and 34 healthy controls.
  • Utilized conventional and tissue Doppler echocardiography at baseline, 2 weeks, and 6 months.
  • Measured parameters including mitral E velocities, mitral E/A ratios, and Tei indices.

Main Results:

  • Neonates with CH showed lower mitral E velocities and mitral E/A ratios at baseline.
  • Tei indices were significantly higher in CH patients, correlating negatively with free thyroxine levels.
  • Systolic function remained normal, but diastolic dysfunction was evident.

Conclusions:

  • Neonates with CH may present with systolic and diastolic cardiac dysfunction.
  • Early L-T4 substitution therapy can reverse cardiac dysfunction in CH.
  • The Tei index is a valuable addition to conventional echocardiography for assessing CH cardiac function.
Abstract

Related Concept Videos

Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...